Page 3 - ஆரோக்கியம் அமைச்சர் கடுமையான News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆரோக்கியம் அமைச்சர் கடுமையான. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆரோக்கியம் அமைச்சர் கடுமையான Today - Breaking & Trending Today

India a step closer to 2nd home-grown Covid-19 vaccine - La Prensa Latina Media


India a step closer to 2nd home-grown Covid-19 vaccine
1 minute read
New Delhi, June 3 (EFE).- India came closer to getting its second indigenous Covid-19 vaccine after the government inked a deal with a pharma company for 300 million doses to be available in the coming months, the health ministry reported Thursday.
The country facing acute vaccine shortages is using a home-grown Covaxin developed by Bharat Biotech laboratory.
Covaxin is used in India’s vaccination drive with British-Swedish firm AstraZeneca’s Covishield and the Russian Sputnik V.
“The proposal of Biological-E was examined and recommended for approval after due diligence by National Expert Group on Vaccine Administration for Covid-19,” the ministry said in a statement. ....

United Kingdom , New Delhi , Harsh Vardhan , Astrazeneca Covishield , Bharat Biotech , Russian Sputnik , National Expert Group , Vaccine Administration , Health Minister Harsh , ஒன்றுபட்டது கிஂக்டம் , புதியது டெல்ஹி , கடுமையான வர்தன் , பாரத் பயோடெக் , ரஷ்ய ஸ்பட்நிக் , தேசிய நிபுணர் குழு , ஆரோக்கியம் அமைச்சர் கடுமையான ,

Guidelines for Using Anti-COVID Drug 2-DG are Out Now


Guidelines for Using Anti-COVID Drug 2-DG are Out Now
by Saisruthi Sankaranarayanan on 
June 3, 2021 at 7:07 PM
Directions for use of 2-DG in COVID-19 patients as per DCGI approval
This Made-in-India drug 2-Deoxy-D-Glucose was developed by DRDO. Previously, the first batch of this drug was released on
17 May by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan.
Key takeaways from the guidelines
‘2-DG must be prescribed to patients who developed moderate to severe forms of SARS-CoV-2 infections and caution must be exercised while using it on people with comorbidities.’
• The drug 2-DG must only be prescribed to COVID patients who have been hospitalized by moderate to severe forms of the infection. ....

Harsh Vardhan , Rajnath Singh , Defence Minister Rajnath Singh , Health Minister Harsh , Covid 19 , 2 Dg , கடுமையான வர்தன் , ராஜ்நாத் சிங் , பாதுகாப்பு அமைச்சர் ராஜ்நாத் சிங் , ஆரோக்கியம் அமைச்சர் கடுமையான ,

COVID: Indian doctors denounce unapproved alternative medicines | Asia| An in-depth look at news from across the continent | DW


COVID: Indian doctors denounce unapproved alternative medicines
Doctors have spoken out against an alarming trend of using unapproved medications to treat coronavirus infections. The comments come after a yoga guru promoted an unapproved treatment and denounced modern medicine.
Indian guru Baba Ramdev claimed he didn t need a COVID vaccine because he was protected by yoga and ancient medicine
Indian medical associations have spoken out against a trend of rejecting modern medicine and using unapproved alternative medications to treat patients infected with COVID-19.
Last month, yoga guru Ram Kisan Yadav, also known as Baba Ramdev, drew intense criticism when he called allopathy, or evidence-based medicine, a stupid science, and claimed that hundreds of thousands had died by taking modern medicines. ....

Uttar Pradesh , Harsh Vardhan , Patanjali Ayurved , Manish Nigam , Navjot Singh Dahiya , Baba Ramdev , Narendra Modi , Patanjali Coronil , Yogi Adityanath , Federation Of Resident Doctor Association , World Health Organization , Ministry Of Ayush , Indian Medical Association , Bharatiya Janata Party , Ram Kisan Yadav , Health Minister Harsh , Swami Ramdevji , Resident Doctor Association , Prime Minister Narendra Modi , Uttar Pradesh Chief Minister Yogi , Minister Vardhan , Black Day , Disaster Management , உத்தர் பிரதேஷ் , கடுமையான வர்தன் , மனிஷ் நீகம் ,

DRDO issues directions on usage of anti-COVID drug 2-DG


DRDO issues directions on usage of anti-COVID drug 2-DG
SECTIONS
Last Updated: Jun 01, 2021, 08:40 PM IST
Share
Synopsis
The Drugs Controller General of India (DCGI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients in early May. The first batch of this oral drug, developed by the Defence Research and Development Organisation (DRDO), was released on May 17 by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan.
Agencies
The DRDO said the drug is approved for emergency use as adjunct therapy to the standard treatment of COVID-19 patients in the hospital settings. ....

Harsh Vardhan , Rajnath Singh , Institute Of Nuclear Medicine , Development Organisation , Defence Research , Drugs Controller General , Defence Minister Rajnath Singh , Health Minister Harsh , Nuclear Medicine , Allied Sciences , Defence Research And Development Organisation , Covid 19 Patients , கடுமையான வர்தன் , ராஜ்நாத் சிங் , நிறுவனம் ஆஃப் அணு மருந்து , வளர்ச்சி ஆர்கநைஸேஶந் , பாதுகாப்பு ஆராய்ச்சி , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , பாதுகாப்பு அமைச்சர் ராஜ்நாத் சிங் , ஆரோக்கியம் அமைச்சர் கடுமையான , அணு மருந்து , கூட்டணி அறிவியல் , பாதுகாப்பு ஆராய்ச்சி மற்றும் வளர்ச்சி ஆர்கநைஸேஶந் ,